Deep Science Ventures

Deep Science Ventures operates as an innovative venture creation platform that unites cutting-edge scientific knowledge with entrepreneurial scientists to develop high-impact companies addressing critical global challenges. Rather than following traditional venture capital models, DSV actively builds ventures from the ground up, employing a systematic methodology that identifies crucial problems and assembles the right scientific talent to solve them. This approach enables the organization to create companies with transformative potential that might otherwise never materialize through conventional startup pathways.

The firm strategically focuses its venture creation efforts across four key sectors: Pharmaceuticals, where they're pioneering novel therapeutic approaches and drug discovery platforms; Climate technologies, addressing decarbonization and sustainability challenges; Agriculture, developing solutions for food security and sustainable farming; and Computation, advancing computational methods that accelerate scientific discovery. Within each sector, DSV applies a first-principles approach, questioning fundamental assumptions and exploring unconventional solutions to intractable problems.

What distinguishes Deep Science Ventures is their collaborative model that partners with leading research institutions, corporations, and funders to maximize venture impact and success probability. These strategic alliances provide DSV-created companies with access to specialized facilities, domain expertise, and initial customer relationships that significantly accelerate their development trajectory. The organization has established partnerships with entities like Cancer Research UK, The Francis Crick Institute, and several major universities to create ventures addressing specific scientific and technological challenges.

Since its founding in 2016, DSV has built an impressive portfolio of deep tech ventures that have collectively raised significant follow-on funding and demonstrated commercial viability. Their ventures typically begin at the pre-seed stage, with DSV providing initial capital, technical guidance, and commercial development support. Notable portfolio companies include Sixfold Bioscience (RNA delivery platform), Entomics (insect-based waste conversion), and Basecamp Research (biodiversity-derived AI models). Through this systematic approach to company building, Deep Science Ventures is actively constructing a future where scientific innovation addresses humanity's most pressing challenges while ensuring planetary sustainability.